Comparable outcomes of patients eligible vs ineligible for SWOG leukemia studies

Patients may be deemed ineligible for a clinical trial for reasons that do not directly impact efficacy or safety. We identified reasons for ineligibility and compared outcomes of ineligible with eligible patients treated on Southwest Oncology Group (SWOG) Leukemia Committee protocols. Patients enro...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Blood
Autors principals: Statler, Abby, Othus, Megan, Erba, Harry P., Chauncey, Thomas R., Radich, Jerald P., Coutre, Steven, Advani, Anjali, Nand, Sucha, Ravandi, Farhad, Mukherjee, Sudipto, Sekeres, Mikkael A.
Format: Artigo
Idioma:Inglês
Publicat: American Society of Hematology 2018
Matèries:
Clinical Trials and Observations
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC6014358/
https://ncbi.nlm.nih.gov/pubmed/29618479
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1182/blood-2018-01-826693
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars